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Framingham Study revealed that the risk of stroke in
subjects with non–insulin-dependent diabetes is 2.6
times higher for men and 3.8 times higher for women
than the risk in nondiabetic patients.4 A Finnish study
based on follow-up (mean, 3.5 years) of 1298 subjects
between the ages of 65 and 74 years confirmed the
increased risk of stroke among diabetic patients, particu-
larly those who were more elderly and those who were
female.5 In a more recent study from Finland, in which
8077 men and 8572 women were followed up for a
mean of 16.4 years, it was confirmed that diabetes is an
important and independent risk factor for stroke. Once
again, the risk was found to be especially high among
women: 33% of all women who die of strokes are diabet-
ics, as opposed to only 16% of men.6
The role of diabetes as a risk factor for carotid surgery
is more controversial. Some groups maintain that the dis-
ease exerts a negative effect on the results of CEA,8,9 but
others insist that the outcomes are no different from those
for nondiabetic patients.10 The purpose of the current
study was to identify the possible short- and long-term
effects of diabetes mellitus on the outcome of CEA.
METHODS
Medical records were reviewed for 781 consecutive
CEAs performed in 734 patients by the same vascular sur-
Carotid endarterectomy (CEA) is justified only
when the complication rate remains below 6% in symp-
tomatic patients and is less than 3% for those without
symptoms.1-3 The main causes of operative mortality in
these cases are myocardial infarction and stroke.
Neurologic complications can be the result of technical
errors during surgery, clamping ischemia, or hemor-
rhage. The identification of patients at risk for these
complications is important because this information
might influence indications and, in some cases, the sur-
gical and anesthesiology techniques to be used.
A number of studies have demonstrated that diabetes
mellitus is an independent risk factor for both stroke and
myocardial infarction.4-7 Alterations in the concentration
and composition of lipoproteins, hyperinsulinemia, and
hyperglycemia itself all contribute to the development of
atherosclerosis, which appears earlier and is more wide-
spread in diabetic than in nondiabetic patients.8 The
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Objective: The purpose of the current study was to identify the possible short- and long-term effects of diabetes on the
outcome of carotid endarterectomy. 
Methods: Medical records were reviewed for 781 carotid endarterectomies (in 734 patients) performed by the same vas-
cular surgeon in a university medical center between January 1994 and December 1998. Patients were divided two
groups: those with diabetes (n = 181 patients; 193 operations) and those without diabetes (n = 553; 588 operations).
The two groups were similar with respect to mean age, male-female ratio, and contralateral lesions. The only signifi-
cant differences were a higher prevalence of peripheral vascular disease and dyslipidemia in the diabetic group and a
higher prevalence of hemispheric transient ischemic attacks among the nondiabetic patients. Carotid color duplex ultra-
sound scan had been performed in all patients, and in 56 patients from the diabetic group and 56 patients from the
nondiabetic group (matched for age, sex, and contralateral lesions), the distal extension of the lesion from the carotid
bifurcation had also been defined. Both of these subgroups were fully representative of their respective groups of ori-
gin. Carotid endarterectomy was performed after the induction of general anesthesia; electroencephalographic moni-
toring was continuous.
Results: Except for the significantly higher prevalence of calcified plaques in the diabetic patients (P < .0001), the char-
acteristics of the carotid disease in the two groups were similar. In the 56-member subgroups, 73.2% of the diabetic
and 35.7% of the nondiabetic patients (P < .0001) had lesions extending more than 2 cm beyond the carotid bifurca-
tion. Mean length of plaque beyond the bifurcation was 2.3 ± 0.09 cm for the diabetic and 1.7 ± 0.08 cm for the non-
diabetic patients (P < .0001). Diabetes was the only factor significantly correlated with plaque length. In the diabetic
subgroup, surgery was characterized by significantly longer carotid arteriotomies (P = .03) and clamp times (P < .003).
Operative mortality was 1.5% in the diabetic group (2 myocardial infarctions + 1 stroke) and 0.5% in the nondiabetic
group (1 myocardial infarction + 2 strokes; P value not significant); stroke rates were 1.5% (3 major strokes) and 0.5%
(2 major strokes + 1 minor stroke), respectively (P = not significant). Long-term survival (5 years) was not significantly
lower among the diabetic patients.
Conclusions: Diabetes mellitus does not seem to significantly increase the surgical risk for carotid endarterectomy. The
presence of more extensive plaques has no significant effect on the results of surgery. (J Vasc Surg 2001;33:148-54.)
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geon (G.R.P.) between January 1994 and December
1998. The patients were divided into two groups, the
principal characteristics of which are shown in Table I.
Group A (24.7% of the total study population) was com-
posed of 181 diabetic patients, including 63 (34.8%) who
were insulin dependent and 118 who were taking oral
hypoglycemics; group B (75.3%) was composed of 553
nondiabetic subjects.
For the purpose of risk-factor analysis, each patient was
classified as a smoker if he or she smoked at least one ciga-
rette per day at the time of admission or had stopped smok-
ing less than 10 years before admission. Hypertension was
defined as a diastolic pressure greater than 90 mm Hg
and/or a systolic pressure of more than 160 mm Hg (as
measured on admission) and/or current use of antihyper-
tensive drugs. Patients with elevated cholesterol and/or
triglycerides levels on admission (measured in all cases) and
those being treated with oral hypolipemics were classified
as having dyslipidemia. Coronary artery disease was
defined on the basis of histories and admission findings. All
patients had undergone cardiologic workups with electro-
cardiograms and echocardiograms on admission. Those
with findings and/or histories indicative of coronary artery
disease had also had Holter monitoring, stress tests,
myocardial scintigraphy, and, in some cases, cardiac
catheterization. The presence of peripheral vascular disease
was documented by means of ultrasonographic studies of
the lower extremities followed by angiography, if indicated.
Color duplex ultrasound scan had been performed in
all patients to define plaque morphology and degree of
stenosis (based on measurements of peak systolic and end-
diastolic velocities).3 One hundred sixty (88.4%) of the
diabetic and 467 (84.4%) of the nondiabetic patients had
also undergone carotid angiography, in which stenosis was
defined according to the North American Symptomatic
Carotid Endarterectomy Trial criteria1 on the basis of the
ratio of the smallest diameter of the vessel at the level of
stenosis to that of the distal segment of the unaffected
internal carotid artery. Comparable findings were
obtained with the two imaging techniques, which con-
firms the observations of various authors11-13 on the accu-
racy of duplex scans. In our analysis, carotid disease was
defined on the basis of ultrasound scan findings.
In patients operated on after September 1996 (85 dia-
betics, 298 nondiabetics), distal extension of the lesion
from the carotid bifurcation had also been recorded during
duplex scanning. To evaluate possible correlations between
plaque size and preoperative risk factors, operative tech-
nique, and/or postoperative morbidity and mortality, we
created two homogeneous subgroups from this subset of
patients: subgroup A (diabetic patients) and subgroup B
(nondiabetic patients). The subgroups (each containing 56
patients) were matched for age, sex, and the presence of
bilateral lesions, and both subgroups were fully representa-
tive of their groups of origin (Table II). Every patient in
the two subgroups underwent single CEA.
In 118 (65.2%) of the patients in group A and 389
(70.3%) of those in group B, cerebral vasomotor reactivity
had been assessed preoperatively by means of transcranial
Doppler (TCD) ultrasound scan through use of the
breath-holding test.14 Cerebrovascular autoregulation was
defined as sufficient when the mean increase in middle
cerebral artery flow velocity exceeded 30%, as diminished
when the mean increase was between 15% and 30%, and as
exhausted when the increase was less than 15%.
Twelve patients (6.6%) from group A and 35 patients
(6.3%) from group B underwent both right and left CEAs
on separate occasions; thus, a total of 193 diabetic carotids
and 588 nondiabetic arteries were operated on. Each CEA
was performed by the same surgeon with the patient
under general anesthesia; electroencephalographic (EEG)
monitoring was continuous. The anesthesiologic risk was
classified according to the parameters of the American
Society of Anesthesiologists.15
Table I. Characteristics and histories of diabetic (group A) and nondiabetic (group B) patients undergoing CEA
Group A (diabetic): n = 181 Group B (nondiabetic): n = 553 P value
Mean age; range (y) 67.3; 56-80 68.1; 48-85 NS
Male 143 pts (79.0%) 416 pts (75.2%) NS
Female 38 pts (21.0%) 137 pts (24.8%) NS
Atherosclerotic risk factors
Smoking 129 pts (71.3%) 404 pts (73.1%) NS
Hypertension 111 pts (61.3%) 356 pts (64.4%) NS
Dyslipidemia 28 pts (15.5%) 54 pts (9.8%) .03
Associated vascular disease
Coronary 48 pts (26.5%) 126 pts (22.8%) NS
Peripheral 62 pts (34.2%) 108 pts  (19.5%) <.0001
Aortic aneurysms 7 pts (3.9%) 39 pts  (7.0%) NS
Neurologic symptoms
Asymptomatic 69 pts (38.1%) 177 pts (32.0%) NS
Hemispheric TIA 69 pts (38.1%) 268 pts (48.5%) .01
Vertebrobasilar TIA 28 pts (15.5%) 58 pts (10.5%) NS
Stroke 15 pts (8.3%) 50 pts (9.0%) NS
pts, Patients.
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To evaluate the possible influence of diabetes on the
surgical procedure itself, we considered the following vari-
ables: length of arterial incision (2 cm or less past the carotid
bifurcation vs more than 2 cm past the carotid bifurcation),
use of tacking sutures, Dacron patch (Intervascular, La
Ciotat, France) closure, and clamp time (in minutes).
Carotid artery patency was verified by means of duplex
Doppler scans in each patient on the day of surgery. In
those who experienced neurologic complications, brain
computed tomography (CT) was performed. Follow-up
evaluations, including color duplex ultrasound scan, were
performed 1, 3, 6, and 12 months after surgery and at
least once a year thereafter. The mean follow-up was 30
months (range, 3 months to 5 years). 
The statistical significance of differences between the
two groups was evaluated through use of the χ2 test.
Differences in clamp time, degree of stenosis, and plaque
extension were assessed by means of 1-way analysis of vari-
ance. Logistic regression analysis was then performed to
identify variables correlated with neurologic and/or car-
diac morbidity/mortality during the postoperative phase.
Variables considered were sex, age (> 65 years), diabetes,
smoking, hypertension, dyslipidemia, coronary artery dis-
ease (cardiac complications only), degree of stenosis, pres-
ence of contralateral lesions, ischemic brain lesions on CT,
and intraoperative shunting (neurologic complications
only). Long-term mortality was evaluated through use of
Kaplan-Meier survival analysis. Statistical significance was
accepted when P was less than .05.
RESULTS
Table I shows the characteristics of the diabetic and
nondiabetic groups. The only significant differences were
the higher frequencies of peripheral vascular disease (P <
.0001) and dyslipidemia (P = .03) among the diabetic
patients and a higher prevalence of hemispheric transient
ischemic attacks (TIAs) among the nondiabetic patients
(P = .01). On the basis of histories and admission findings,
coronary artery disease was found to be slightly more
common among the diabetic patients, although this dif-
ference was not significant. As shown in Table III, the
clinical characteristics of coronary artery disease in these
patients was not significantly related to diabetes.
Table IV shows the characteristics of the carotid disease
in groups A and B based on the results of (1) color duplex
ultrasound scan (in most cases) or angiography and (2) CT.
On average, stenosis was slightly more severe in arteries
from the diabetic group, although CT-documented
ischemic brain lesions were somewhat less common in
these patients. However, the only significant difference
between the two groups was the prevalence of calcified
plaques identified by ultrasound scan studies, which was
significantly higher in Group A (168/193 [87.0%] of the
diabetic carotids operated on vs 249/588 [42.3%; P <
.0001] of the arteries treated in Group B).
TCD findings in 118 diabetic and 389 nondiabetic
patients showed that cerebral vasomotor reactivity was suf-
ficient in 69 diabetic (58.5%) vs 244 nondiabetic patients
(62.7%; P value not significant [NS]), diminished in 37
diabetic (31.4%) vs 101 nondiabetic patients (26.0%; P
value NS), and exhausted in 12 diabetic (10.2%) vs 44
nondiabetic patients (11.3%; P value NS).
Ultrasound scan or angiographic characteristics of the
carotid disease in subgroups A and B are shown in Table
V. The two subgroups differed significantly only in mean
plaque length beyond the bifurcation and number of
lesions extending for more than 2 cm beyond the bifurca-
tion; both of these were significantly higher for the dia-
betic subgroup. Multivariate analysis showed that plaque
length was not correlated with smoking, hypertension,
dyslipidemia, sex, or age, but there was a highly significant
correlation with diabetes (P = .0001).
Table II. Characteristics and histories of subgroups A (diabetics) and B (nondiabetics): comparisons with groups of origin
Subgroup A P value Subgroup B P value 
(diabetic): n = 56 (vs group A) (nondiabetic): n = 56 (vs group B)
Mean age; range (y) 66.7 (58-80) NS 66.9 (43-80) NS
Male 48 pts (85.7%) NS 46 pts (82.1%) NS
Female 8 pts (14.3%) NS 10 pts (17.9%) NS
Atherosclerotic risk factors
Smoking 41 pts (73.2%) NS 44 pts (78.6%) NS
Hypertension 29 pts (51.8%) NS 36 pts (64.3%) NS
Dyslipidemia 4 pts (7.1%) NS 6 pts (10.7%) NS
Associated vascular disease
Coronary 16 pts (28.6%) NS 16 pts (28.6%) NS
Peripheral 24 pts (42.9%) NS 11 pts (19.6%) NS
Aortic aneurysms — NS 1 pt (1.8%) NS
Neurologic symptoms
Asymptomatic 21 pts (37.5%) NS 17 pts (30.4%) NS
Hemispheric TIA 22 pts (39.3%) NS 28 pts (50.0%) NS
Vertebrobasilar TIA 8 pts (14.3%) NS 7 pts (12.5%) NS
Stroke 5 pts (8.9%) NS 4 pts (7.1%) NS
pts, Patients.
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The operative risk was classified as American Society of
Anesthesiologists group III-IV in 34.2% of the diabetic
patients (n = 62); this compared with 26.6% of the nondi-
abetic patients (n = 147), but the difference was not sta-
tistically significant.
Cross-clamping was associated with EEG changes
requiring temporary shunting in a slightly lower percent-
age of the operations performed on diabetic patients
(23/193 [11.9%] vs 78/588 [13.3%] for nondiabetic
patients; P value NS). A more distal dissection and a longer
arteriotomy were required in a higher percentage of the
operations performed on diabetic patients, and the mean
clamp time for the CEAs in subgroup A was also signifi-
cantly longer. Analysis of surgical variables in subgroups A
and B (Table VI) revealed that longer arteriotomies (> 2
cm past the bulb) were significantly more common in the
diabetic subgroup, which reflects the presence of longer
plaques seen on preoperative ultrasound scan studies. As a
result, clamp time was also significantly prolonged in sub-
group A. Tacking sutures and Dacron patches were used
with similar frequencies in the two subgroups. 
Short-term (ie, 30-day) mortality/morbidity figures are
shown in Table VII. The overall rate of complications was
quite good, and with respect to mortality rates the two
groups were not significantly different. Strokes were actually
more common among the nondiabetic patients, although
this difference was not significant. The only significant dif-
ference was a higher rate of nonfatal complications in group
A (P = .02). Multivariate analysis revealed no significant cor-
relation between neurologic or cardiac complications and
any of the variables assessed (including diabetes).
Postoperative duplex scans confirmed the patency of
the carotid arteries that had been operated on in all
patients, including those who had experienced neurologic
complications. In all of the latter patients, neurologic
deficits were observed as soon as the patients regained
consciousness. Brain CTs showed no hemorrhages. In one
patient from group B, a review of the intraoperative EEG
tracing revealed clamp ischemia that had not been
reported by the neurologist during surgery. All of the
remaining neurologic complications were, in our opinion,
caused by embolic phenomena.
Of the 728 patients who survived the first 30 days after
surgery, 70 were lost to follow-up; long-term data were
thus available for 166 (91.7%) of the group A patients and
492 (89%) of the group B patients. The overall mortality
rate for the population analyzed, with a mean follow-up of
30 months (range, 3 months to 5 years), was 11.8% (78
patients): 17.5% (29 patients) for group A and 10% (49
patients) for group B (P value NS). The single most fre-
quent cause of long-term mortality was coronary artery dis-
ease (39 patients [50%]: 14 [48.3%] from group A and 25
[51%] from group B [P value NS]). Cancer was the second
most common cause of death (18 patients [23.1%]: 7
[24.1%] from group A and 11 [22.4%] from group B [P
value NS]) and stroke the third (3 patients [3.8%]: none
from group A and 3 [6.1%] from group B [P value NS]).
Nonfatal strokes occurred in three patients (0.5%): 1 (0.7%)
from group A and 2 (0.4%) from group B (P value NS).
DISCUSSION
Data from several randomized multicenter trials con-
firm that surgical treatment is superior to medical manage-
ment in the prevention of stroke in symptomatic and
asymptomatic patients with severe carotid stenosis.1-3
These studies have also shown, however, that the benefits
Table III. Characteristics of diabetic and nondiabetic patients with coronary artery disease who underwent CEA
Characteristic From group A (diabetic): 48 pts* From group B (nondiabetic): 126 pts† P value
Myocardial infarction 32 pts (66.7%) 64 pts (50.8%) NS
Congestive heart failure 7 pts (14.6%) 23 pts (18.2%) NS
Angina 5 pts (10.4%) 21 pts (16.7%) NS
Coronary revascularization 4 pts (8.3%) 18 pts (14.3%) NS
*Consisting of 26.5% of group A.
†Consisting of 22.8% of group B.
pts, Patients.
Table IV. Characteristics of carotid disease* in diabetic and nondiabetic patients who underwent CEA
Characteristic Group A (diabetic): n = 181 Group B (nondiabetic): n = 553 P value
Unilateral carotid stenosis 114 pts (63.0%) 366 pts (66.2%) NS
Bilateral carotid stenosis 43 pts (23.8%) 116 pts (21.0%) NS
Contralateral carotid occlusion 24 pts (13.2%) 71 pts (12.8%) NS
Percent stenosis (mean ± SEM) 84.1% ± 0.97% 82.8% ± 0.61% NS
Ischemic brain lesions on CT 56 pts (30.9%) 190 pts (34.4%) NS
*Findings are based on duplex Doppler scan data.
pts, Patients.
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of surgery, in terms of stroke risk reduction, are inversely
proportional to the rate of perioperative complications.
Maintaining cumulative mortality/morbidity rates within
acceptable limits depends on the criteria used for patient
selection, the surgical and anesthesiologic techniques used,
and the prevention of intraoperative and postoperative
complications. Identification of high-risk patients is partic-
ularly important, inasmuch as the presence of certain con-
ditions may influence treatment options and indications,
surgical strategies, and/or the approach to anesthesia. 
Risk assessment in a candidate for CEA is based on a
number of factors, including neurologic symptoms,
plaque characteristics, unilateral vs bilateral involvement,
vasomotor reactivity, and the presence of ischemic brain
lesions on CT.16-19 A complete understanding of the
patient’s general condition can play an important role in
reducing perioperative morbidity and mortality and
improving the long-term prognosis. The single most
important factor to consider in the timing of carotid
surgery is the cardiologic risk,20 and arterial hypertension,
which promotes hemorrhage and myocardial infarction, is
unanimously regarded as a major risk factor.21-25
The significance of diabetes mellitus is somewhat less
clear, and not all investigators agree that the disease is an
independent risk factor for cardiac and neurologic compli-
cations after CEA. In 1990, Salenius et al8 affirmed that
diabetes was indeed a predictor of post-CEA stroke, which
occurred in 20% of diabetic patients but only 8.2% of
those without diabetes. This conclusion was based on the
authors’ retrospective analysis of a series of patients oper-
ated on between 1965 and 1984, and its value is limited
by an overall frequency of neurologic complications that is
clearly unacceptable by today’s standards. In a more recent
study of 732 patients, 284 of whom were diabetics, Akbari
et al10 found that neurologic morbidity and mortality
were similar in the two groups. However, cardiac compli-
cations were decidedly more common among the diabetic
patients; this was due, in all probability, to the significantly
higher prevalence of preexisting heart disease in these
patients. In contrast, the study by Ombrellaro et al20 of
266 patients with CEA, including 62 diabetic patients,
revealed no significant difference with respect to the rate
of cardiac complications between patients with and
patients without diabetes (14% and 16%, respectively).20
In the current series, the diabetic and nondiabetic
groups were not significantly different as far as the preop-
erative prevalence of heart disease is concerned. People
with diabetes are known to have a higher-than-normal
incidence of silent myocardial disease,26-29 however, and
the true rates of coronary artery disease in our study
groups is unknown, inasmuch as stress tests, Holter mon-
itoring, myocardial scintigraphy, and cardiac catheteriza-
tion were not routinely included in the preoperative
cardiac workup. Nonetheless, the surgical results achieved
in the diabetic patients were good. Multivariate analysis
showed that diabetes mellitus is not an independent risk
factor for post-CEA morbidity or mortality. 
From a clinical point of view, the significantly higher
prevalence in the diabetic group of peripheral vascular dis-
ease (P < .0001) reflects the more extensive atherosclerotic
involvement in these subjects. Recent ultrasound scan
studies have shown that intima-media thickening occurs
earlier and atherosclerotic plaques are more common in
diabetic patients without any cerebrovascular symptoms
than in nondiabetic patients.30-32 Hyperinsulinemia seems
to play a central role in this process by stimulating the pro-
Table V. Characteristics of carotid disease in subgroups A (diabetic) and B (nondiabetic) in which plaque length was
measured ultrasonographically
Group A (diabetic): n = 181 Group B (nondiabetic): n = 56 P value
Unilateral carotid stenosis 35 pts (62.5%) 35 pts (62.5%) NS
Bilateral carotid stenosis 13 pts (23.2%) 13 pts (23.2%) NS
Contralateral carotid occlusion 8 pts (14.3%) 8 pts (14.3%) NS
Percent stenosis (mean ± SEM) 83.2% ± 1.55% 82.9% ± 1.54% NS
Mean length of plaque (cm) 2.3 ± 0.09 1.7 ± 0.08 <.0001
Lesion size > 2 cm 41 pts (73.2%) 20 pts (35.7%) <.0001
Ischemic brain lesions on CT 16 pts (28.5%) 19 pts (33.9%) NS
pts, Patients.
Table VI. Analysis of surgical variables in subgroups A (diabetic) and B (nondiabetic)
Surgical variable Subgroup A (diabetic): n = 56 Subgroup B (nondiabetic): n = 56 P value
Longer arteriotomies (> 2 cm) 12 pts (21.4%) 4 pts (7.1%) .03
Clamp time (min) 24.1 ± 0.73 21.5 ± 0.44 <.003
Dacron patches 12 pts (21.4%) 9 pts (16.1%) NS
Tacking sutures 7 pts (12.5%) 4 pts (7.1%) NS
pts, Patients.
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liferation and migration of smooth muscle cells, increasing
lipid stores in muscle cells and fibroblasts, reducing the
elimination of cholesterol from foam cells, and stimulating
the release of growth factors.33
The influence of diabetes on neurologic morbid-
ity/mortality is also the subject of some debate. In the
current study, fatal and nonfatal neurologic events were
slightly, though not significantly, more common in the
diabetic group despite the fact that this group contained
higher percentages of asymptomatic patients and patients
without ischemic lesions before surgery. Calcified plaques
were significantly more common in group A, which also
presented a higher mean percentage of stenosis. The rela-
tive stability of calcified plaques and the fact that ultra-
sound scan screening studies are performed more
frequently in diabetics may explain the higher number of
asymptomatic subjects in this group, which is consistent
with the findings of other investigators,30,34 as well as the
lower rate of ischemic lesions on preoperative CT.
Skydell et al9 found that diabetes was the only variable
associated with post-CEA hypertensive crises leading to
neurologic complications and hypothesized that the role
of the disease was based primarily on the negative effects
that it exerts on cerebrovascular autoregulation. However,
this conclusion is in contrast with our previous observa-
tions35,36 and the results of TCD ultrasound scan in the
current study. The percentage of patients with exhausted
cerebral vasomotor reactivity in group A was not any
higher than that in group B, and clamp ischemia, which is
a reflection of the inefficiency of collateral circulation and
vasomotor autoregulation, was actually less common in
the diabetic group (11.9% of the operations) than in the
nondiabetic group (13.1%).
Riles et al37 analyzed the causes of stroke after CEA and
concluded that 65% of these events can be attributed to sur-
gical errors. In their study of 2365 patients (3062 CEAs),
the overall incidence of stroke was 2.2%, as opposed to 3.6%
for the subgroup with diabetes. Even in the latter cases, how-
ever, technical errors appeared to play a central role, and the
authors concluded that the brains of diabetic patients seem
to be more susceptible to ischemic insults. This hypothesis is
supported by data from studies on experimentally induced
diabetes,38 in which the incidence of brain damage after
ischemic insults was found to be higher in the presence of
altered glucose metabolism. Prompted by these observa-
tions, we attempted to determine how plaque characteristics
in the diabetic affect surgical technique. This analysis was
limited to subgroups of the diabetic and nondiabetic patients
because plaque dimensions had not been recorded on duplex
Doppler scans performed in the earlier cases. As shown in
Tables II and V, however, these subgroups were fully repre-
sentative of their groups of origin. Ultrasound scan data on
plaque length could not be confirmed by intraoperative mea-
surements, which were unavailable in most of these patients’
charts, but our experience (unpublished data), as well as that
of other investigators,39 indicates that this noninvasive
method provides highly accurate data on plaque morphol-
ogy and dimensions even in the presence of heavy calcifica-
tion. Our findings show that diabetes is a major independent
predictor of plaque length in patients undergoing CEA, and
this factor was associated with longer arteriotomies and
longer clamp times in the diabetic subgroup. However,
although almost all of the neurologic complications
observed in the current series appear to be related to intra-
operative embolization, these events occurred with similar
frequencies in the diabetic and nondiabetic groups.
Moreover, diabetes did not seem to be a negative prognos-
tic factor as far as long-term survival after CEA is concerned.
Although the overall long-term mortality rate was
higher among the diabetic patients whom we studied than
among the nondiabetic patients (17.5% vs 10%), this differ-
ence was not statistically significant. Moreover, in both
groups, more than half of the deaths that occurred after the
first 30 days were related to myocardial infarction, but these
events were actually somewhat more frequent among non-
diabetic patients. Strokes, both fatal and nonfatal, were also
slightly more common in group B. Our findings thus con-
trast with those of Hallett et al,40 who studied a series of
254 cases of CEA performed at the Mayo Clinic (Rochester,
Minn) between 1970 and 1995. In that investigation, there
was a drastically reduced 8-year survival rate among the 56
diabetic patients of the study population—ie, 27% vs 67% in
controls (P = .002). The significance of this discrepancy is
difficult to explain, but it might simply reflect the longer
follow-up of the Mayo Clinic study (8 years vs 5 years in the
current study).
CONCLUSIONS
Our experience indicates that diabetes is associated with
(1) atherosclerotic disease that is more diffuse than that seen
Table VII. Short-term (30-day) mortality and morbidity in diabetic (group A) and nondiabetic (group B) patients
undergoing CEA
Group A: diabetics Group B: nondiabetics Total P value
No. of operations 193 588 781 —
Fatal cardiac events 2 (1.0%) 1 (0.2%) 3 (0.4%) NS
Fatal neurologic events 1 (0.5%) 2 (0.3%) 3 (0.4%) NS
Mortality (all causes) 3 (1.5%) 3 (0.5%) 6 (0.8%) NS
Nonfatal cardiac events 2 (1.0%) 1 (0.2%) 3 (0.4%) NS
Nonfatal neurologic events 4 (2.1%) 4 (0.7%) 8 (1.0%) NS
Morbidity (all causes) 6 (3.1%) 5 (0.8%) 11 (1.4%) .02
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in nondiabetic patients and (2) more extensive plaques in
the internal carotid arteries. However, diabetes does not
appear to be an independent risk factor either for cardiac or
neurologic events (fatal or nonfatal) after CEA or for the
long-term rates of mortality and morbidity. Therefore, in
our opinion, CEA remains the most effective means for pre-
vention of stroke, even for this group of patients.
We gratefully acknowledge the contribution of Marian
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